FIRST
DRUG in the world
approved to treat
Favipiravir-based
COVID-19

HBV is the leading cause of cancer-related morbidity and mortality worldwide

First ORAL drug
APPROVED to treat
COVID-19
AVIFAVIR delivered to
over 200,000 patients
& 16 countries worldwide
Slider

Compas

12760 High Bluff Dr., San Diego, CA, 92130

 bottle

CHR101 has the potential to eradicate HBV and to cure chronically infected HBV patients

 

Calendar

Learn more about our news and events in 2020